IRVINE, CA -- (Marketwire) -- 02/27/09 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today announced the global launch of its new Waterlase® MD Turbo(TM) hard and soft tissue dental laser system. The most important benefit of the Waterlase MD Turbo is the speed of cutting cavity preparations which can now be completed as quickly as with the high-speed drill. The Waterlase MD Turbo will be introduced at the Chicago Dental Society Midwinter Meeting being held February 26-March 1 in Chicago.
The Waterlase MD Turbo offers significant upgrades, including a new handpiece with newly released software that recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Other benefits include longer tip life; greater system reliability, especially for the laser delivery system; and an improved user interface compared to the current Waterlase MD, that simplifies selection of tips and settings. The Waterlase MD Turbo will be shipped to new customers beginning in March. The Company plans to make available upgrade kits for the existing customer installed base later in 2009.
Dr. Dan Jenkins, D.D.S., a Waterlase user for the past four years, said, "When I used the Waterlase MD Turbo for the first time, I was very impressed with how fast it cut as well as the length of the tip for reaching down into the tooth. Even with the Waterlase MD Gold handpiece, the Waterlase MD Turbo is significantly faster making it comparable to a high-speed drill."
Chief Executive Officer Jake St. Philip said, "This is a significant breakthrough for BIOLASE in improving the speed of the flagship Waterlase MD. A long-standing objection to laser adoption has been the speed of cutting as compared to the drill, but we will now rival that cutting speed for many routine procedures. We believe the addition of the Waterlase MD Turbo will accelerate the worldwide adoption of dental lasers as a standard and increase sales of our laser systems."
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports, and include the risk that the company may not be able to obtain a new line of credit. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.
For further information, please contact:
David M. Mulder
Chief Financial Officer
BIOLASE Technology, Inc.
Allen & Caron